Navigation Links
CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards
Date:4/30/2008

WOBURN, Mass., April 30 /PRNewswire/ -- AstraZeneca, Eli Lilly and Rx Canada received top honors at the 2008 Strategic Patient Adherence (SPA) Awards. Rx Canada and their client (AstraZeneca Canada), the first international award winners, received awards for the Best Branded Compliance Program. The Health Inform(R) Programs for Crestor, Symbicort and Nexium medications were lauded for measurement of each program's effectiveness. "I really liked the way in which they measured and published their results," said Robert Nauman, BioPharma Advisors and a judge for the SPA awards. Rx Canada and their client (Eli Lilly Canada) received an innovation award for the Evista Inner Strength Program which ensured that pharmacists followed up with patients 2 weeks after their first intervention. Finally, AstraZeneca received an innovation award for the SERV(TM) Program, which is a platform that allows AZ brands to leverage the sales force to provide messages, tools and programs to physicians toward enhancing medication adherence in their patients.

The prestigious Strategic Patient Adherence (SPA) Awards co-sponsored by CBI and PharmaVoice were presented at the 7th Annual Forum on Patient Compliance, Adherence and Persistency held April 24th in Philadelphia, PA. These awards provided a forum that pays tribute to outstanding programs in the areas of patient compliance/adherence and persistency.

Awards were given to pharmaceutical organizations that met pre-defined criteria in 5 categories: Innovation, Quality, Measurement, Satisfaction, Health Outcomes & ROI. Programs that have been deemed exceptional in their compliance initiatives usually score above 60 points on the judging scale. Each entry was reviewed by this year's judging panel made up of Grant Corbett, Founder of Behavior Change Solutions, Inc., Robert Nauman, Principal at BioPharma Advisors, John Heilman, Senior Commercial Analytics Manager, New Practice and Corporate Analytics, AstraZeneca, Glenn Gary, Senior Marketing Manager, Amgen, and Dorothy L. Smith, Pharm.D, President of Consumer Health Information. Both John and Gary are previous award winners of the SPA award.

"The SPA awards were a success because these programs incorporate the best practices that occur in the industry today. This year's winners proved the value and validity against some nationally recognized criteria for patient compliance, adherence and persistency programs," said Grant Corbett, Principal, Behavior Change Solutions and a judge for the SPA awards.

For information about next year's awards please contact Jackie Harrington at 781-939-2405 or Email: Jackie.harrington@cbinet.com

About CBI Research, Inc. (http://www.cbinet.com)

Founded in 1994 in Massachusetts, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticals\biotech, medical devices, risk and insurance and managed care markets. CBI Research, Inc. offers conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation. As a delegate, speaker or sponsor, you receive timely information on the latest investment opportunities, business strategies, domestic and international regulatory issues, operations and applied technologies. Our events provide you with concrete, real life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. Plus, there are extensive opportunities for networking and discussion with senior policy and decision makers. CBI Research, Inc. was acquired by Advanstar Communications, Inc. in February of 2008.


'/>"/>
SOURCE CBI Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
3. Beckman Coulter Announces First Quarter 2008 Results
4. Onyx Pharmaceuticals Announces First Quarter 2008 Financial Results Teleconference and Webcast
5. BioMarin Announces First Quarter 2008 Financial Results
6. Align Technology Announces $50 Million Stock Repurchase Program
7. Anesiva Announces New Zingo Marketing and Distribution Agreement
8. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
9. Genomic Health to Announce First Quarter 2008 Financial Results and Host Conference Call on Tuesday, May 6, 2008
10. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
11. Syndexa Pharmaceuticals Corporation and ChemDiv, Inc. Announce Discovery Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet Products ... properties for use in harsh environments inside or outside of the human body. ... metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation ...
(Date:1/7/2020)... (PRWEB) , ... January 06, 2020 , ... ... a Digital World at The Fletcher School at Tufts University, is pleased to ... Foundation. The grant will be administered by Tufts University, and will help to ...
(Date:12/31/2019)... ... 2019 , ... At this year's SLAS conference, Visikol will present several talks ... 3D cell culture , advanced imaging and multiplex analysis . Specifically, ... steatosis , inflammation and fibrosis as well as a 2D cell culture ...
(Date:12/23/2019)... N.J. (PRWEB) , ... December 23, 2019 , ... ... based leak detection systems for the Pharmaceutical, Biotechnology and Medical Device Industries, is ... presenter at the Parenteral Drug Association (PDA) Container Closure Integrity Testing Basic ...
Breaking Biology Technology:
(Date:2/5/2020)... ... February 05, 2020 , ... ... greater ease, efficiency and insight to sample processing within laboratories. , Built ... laboratories conducting research in various fields, LabKey Sample Manager has been designed with ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... it will start production of a DNA vaccine against the novel coronavirus (2019-nCoV) ... Pharmaceuticals. A grant of up to $9 million from the Coalition for Epidemic ...
(Date:1/24/2020)... ... January 24, 2020 , ... Shoreline Biome , ... strain level, today announced that the company will debut a novel new DNA isolation ... , The new product, Shoreline Biome's Rapid Prep kit, is a fast and easy-to-use ...
Breaking Biology News(10 mins):